TEMPUS AI, INC. (TEM)
Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense
Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense
Entrada Therapeutics Reports First Quarter 2026 Financial Results
Gilat to Present at Upcoming Investor Conferences
Ironwood - Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance
REGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy 2026 Annual Meeting
Tripadvisor, Inc. Earnings Press Release Available on Companys Investor Relations Site
Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance
Xometry Reports Record First Quarter 2026 Results
Appian Announces First Quarter 2026 Financial Results
Iovance Biotherapeutics Highlights Positive First Quarter 2026 Results, Business Achievements and Corporate Updates